DISTAL RENAL TUBULAR ACIDOSIS

 

DISTAL RENAL TUBULAR ACIDOSIS

 

DEFINITION:

A renal disorder characterized by the inability of the collecting duct to decrease the urinary pH below 5.5 resulting in an excessive urinary loss of bicarbonate.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • first year of life with failure to thrive
  • risk factors:
    • see below

PATHOGENESIS:

1. Etiology

  • Distal Renal Tubular Acidosis (RTA) represents the uniform response of the distal renal tubules to various exogenous and endogenous insults that spare the glomeruli but result in a generalized pattern of tubular dysfunction
  • types of insults:

1. Primary

1. Permanent

  • 1. Classic Form
  • 2. Variants
  • 1. Incomplete
  • 2. With Nerve Deafness
  • 2. Transient

  • 1. Infantile Form
  • 2. Secondary

    1. Conditions Associated with Nephrocalcinosis

  • 1. Hypomagnesemia-hypercalciuria with nephrocalcinosis
  • 2. Hypercalcemic Hyperthyroidism
  • 3. Idiopathic Hypercalciuria with Nephrocalcinosis
  • 4. Primary Hyperparathyroidism
  • 5. Vitamin D intoxication
  • 2. Hyperglobulinemic States

  • 1. Autoimmune Thyroid Disease
  • 2. Chronic Active Hepatitis
  • 3. Cryoglobulinemia
  • 4. Fibrosing Alveolitis
  • 5. Hyperglobulinemic Purpura
  • 6. Idiopathic Hypergammaglobulinemia
  • 7. Macroglobulinemia
  • 8. Multiple Myeloma
  • 9. Plasma Cell Nephropathy
  • 10. Primary Hepatic Cirrhosis
  • 11. Sjogren's Syndrome
  • 12. SLE
  • 3. Hyponatriuric States

  • 1. Hepatic Cirrhosis
  • 2. Nephrotic Syndrome
  • 4. Drugs and Toxins

  • 1. Amphotericin B
  • 2. Lithium
  • 3. Toluene
  • 5. Renal Disease

  • 1. kidney transplantation
  • 2. Medullary Sponge Kidney
  • 3. obstructive uropathy
  • 6. Genetic Disorders

  • 1. Ehlers-Danlos syndrome
  • 2. Hereditary Elliptocytosis
  • 3. Hereditary Fructose Intolerance with Nephrocalcinosis
  • 4. Osteopetrosis
  • 5. Sickle Cell Disease
  • 6. Wilson's Disease
  • 7. Endocrine Disorders

  • 1. Congenital Adrenal Hyperplasia (salt-loosing)
  • 2. hypothyroidism
  • 2. Pathogenesis

    • the pathophysiologic mechanism(s) is unknown but 3 main defects have been identified:

    1. Secretory Defect

    • failure of the collecting ducts to secrete hydrogen ion due to:
      • decreased number or impaired function of hydrogen ion secretory pumps
      • structural defects in the luminal membrane of the collecting ducts
      • an impaired energy supply
    • results in an inability to reduce the urine pH to less than 5.5

    2. Voltage Dependent Defect

    • inability of distal nephrons to generate and/or maintain a negative intratubular potential difference due:
      • a defect in sodium delivery and/or transport -> persistent distal defect in sodium reabsorption
    • would reduce secretion of both hydrogen ions & K+

    3. Gradient Defect

    • increased permeability of the luminal membrane to H+, carbonic acid, or bicarbonate

    1. Bicarbonaturia

    • there is excessive HCO3 loss during the first few years of life (5 mEqu/kg/d) which then decreases to 1-2 mEqu/kg/d by school age and is suggestive of a coexisting dysfunction of the proximal tubules
    • since the distal tubule is unable to reabsorb the 15% HCO3 load from the proximal tubule, the excess HCO3 in the distal tubule stimulates sodium reabsorption in exchange for potassium leading to hypokalemia
    • contraction of the extracellular volume stimulates chloride reabsorption resulting in hyperchloremia and secretion of aldosterone which leads to further potassium loss

    2. Chronic Acidosis

    • the persistent acidosis requires buffering by alkaline salts of bone and results in the release of calicum from bone ->
      • the resultant hypercalciuria leads to nephrocalcinosis, nephrolithiasis, and renal parenchymal destruction
      • osteomalasia

    CLINICAL FEATURES:

    1. Permanent Classical Form (Butler Albright Syndrome)

    • age of onset: anytime after 2 years through to adulthood
    • risk factors: slight female predominance

    1. Non-Specific Manifestations

    • constipation
    • dyspnea of exertion
    • failure to thrive
    • growth retardation
    • nausea and vomiting
    • polyuria/dehydration

    2. Complications

    1. Renal

    • nephrocalcinosis
    • urolithiasis (may be the initial complaint [in adults])
    • chronic interstitial nephritis
    • severe hypokalemia crises
      • dehydration, shock, arrhythmias, vomiting, flaccid paralysis, respiratory distress, drowsiness, coma

    2. Musculoskeletal

    • arthralgia, low back pain, myalgia, osteomalacia, rickets

    3. Clinical Variants

    1. "Incomplete" Distal RTA

    • nephrocalcinosis without metabolic acidosis

    2. Distal RTA with Nerve Deafness

    2. Transient Form (Lightwood's Syndrome)

    • age of onset: infancy
    • may represent a transient self-limited form of distal RTA in infancy

    1. Non-specific Manifestations

    • anorexia
    • constipation
    • failure to thrive
    • muscular weakness
    • nausea and vomiting

    INVESTIGATIONS:

    1. Serum

    • normal anion gap hyperchloremic metabolic acidosis (with low serum HCO3)
    • hypokalemia, hyponatremia, hypophosphatemia
    • normal or slightly elevated calcium
    • normal or slightly elevated phosphate
    • normal or decreased glomerular filtration rate (GFR)
    • elevated parathyroid hormone

    2. Urine

    • pH >5.5 (usually between 6-7)
    • hypercalciuria
    • aminoaciduria (with severe bone disease)
    • bicarbonaturia
    • tubular proteinuria
    • leukocyturia
    • elevated rate of excretion of phosphate, calcium, and potassium
    • decreased rate of excretion of citrate, ammonium, titratable acid

    3. Imaging Studies

    1. Renal (Ultrasound/CT/X-Rays)

    • nephrocalcinosis (may appear within the 1st few months of life)
    • nephrolithiasis, urolithiasis

    2. Musculoskeletal

    • rickets, osteomalacia

    4. Pathology

    1. Kidney

    • early - normal
    • late - complications
      • nephrocalcinosis
      • chronic interstitial nephritis
        • cellular infiltration, tubular atrophy, glomerular sclerosis

    MANAGEMENT:

    1. Medical

    1. Oral Alkali Supplements

    • potassium citrate
      • may relieve hypocitraturia
      • may decrease rate of stone formation
    • sodium or potassium bicarbonate
    • corrects metabolic acidosis
    • maintains normal rate of calcium excretion
    • lifelong therapy and attempts to withdraw results in the reappearance of metabolic acidosis and related symptoms - may halt progression of nephrocalcinosis and growth retard-ation but not polyuria

    2. Potassium Supplements

     

     

    Pediatric Database - DISTAL RENAL TUBULAR ACIDOSIS

    Pediatric Organization - Pedbase [at] Gmail.com